ACADIA Pharmaceuticals Inc. (LON:0A4W)
18.62
-0.02 (-0.11%)
At close: Jan 31, 2025
ACADIA Pharmaceuticals Market Cap
ACADIA Pharmaceuticals has a market cap or net worth of 3.48 billion as of December 5, 2025. Its market cap has increased by 63.73% in one year.
Market Cap
3.48B
Enterprise Value
2.89B
Revenue
778.99M
Ranking
n/a
PE Ratio
17.93
Stock Price
18.62
Market Cap Chart
Since May 27, 2004, ACADIA Pharmaceuticals's market cap has increased from 61.44M to 3.48B, an increase of 5,570.82%. That is a compound annual growth rate of 20.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 3.48B | 42.87% |
| Dec 31, 2024 | 2.44B | -39.57% |
| Dec 29, 2023 | 4.04B | 88.62% |
| Dec 30, 2022 | 2.14B | -22.79% |
| Dec 31, 2021 | 2.77B | -55.49% |
| Dec 31, 2020 | 6.22B | 25.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.77B |
| HSBC Holdings | 182.10B |
| Shell | 158.59B |
| Unilever | 110.94B |
| Rio Tinto Group | 94.53B |
| British American Tobacco p.l.c. | 93.13B |
| Rolls-Royce Holdings | 90.78B |
| GSK plc | 72.45B |